# Quoin Pharmaceuticals, Ltd. (QNRX) insider trading, Q3 2026

Canonical: https://sec-api.dev/insider-trading/qnrx

> 6 non-derivative transactions: 4 purchases ($280K), 0 sales. CIK 1671502.

| Date | Insider | Relationship | Code | Shares | Price | Owned after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-31 | Culverwell Anthony James | Director | P | 6146.0 | 4.88 | 40364.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926104402/0001104659-26-104402-index.htm |
| 2026-08-31 | Lawlor Sally Bridget | Officer | P | 10244.0 | 4.88 | 10684.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926104403/0001104659-26-104403-index.htm |
| 2026-08-31 | Myers Michael | Director, Officer | P | 20490.0 | 4.88 | 37713.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926104404/0001104659-26-104404-index.htm |
| 2026-08-31 | Carter Denise P. | Director, Officer | P | 20490.0 | 4.88 | 37709.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926104405/0001104659-26-104405-index.htm |
| 2026-08-27 | Culverwell Anthony James | Director | A | 31352.0 | 5.15 | 34218.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926103374/0001104659-26-103374-index.htm |
| 2026-08-27 | LANGER DENNIS | Director | A | 34534.0 | 5.15 | 56243.0 | https://www.sec.gov/Archives/edgar/data/1671502/000110465926103376/0001104659-26-103376-index.htm |

Source: https://www.sec.gov/data-research/sec-markets-data/insider-transactions-data-sets

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up